PAPPA2 as a Therapeutic Modulator of IGF-I Bioavailability: in Vivo and in Vitro Evidence

M Andrew, L Liao, M Fujimoto, J Khoury… - Journal of the …, 2018 - academic.oup.com
Context Pregnancy-associated plasma protein A2 (PAPPA2) is a protease that cleaves IGF-
binding protein (IGFBP)-3 and IGFBP-5, liberating free IGF-I. Five patients from two families …

Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation

M Fujimoto, M Andrew, L Liao, D Zhang… - …, 2019 - academic.oup.com
Bioactive free IGF-I is critically important for growth. The bioavailability of IGF-I is modulated
by the IGF-binding proteins (IGFBPs) and their proteases, such as pregnancy-associated …

Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects

M Fujimoto, M Andrew, A Dauber - Molecular and cellular endocrinology, 2020 - Elsevier
Growth hormone (GH) and its mediator, insulin-like growth factor-1 (IGF-1), have long been
recognized as central to human growth physiology. IGF-1 is known to complex with IGF …

Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood

M Fujimoto, JC Khoury, PR Khoury… - European journal of …, 2020 - academic.oup.com
Objective Pregnancy-associated plasma protein-A2 (PAPP-A2) is a metalloproteinase that
cleaves IGFBP-3 and IGFBP-5. Human mutations in PAPPA2 result in short stature with a …

Mutations in pregnancy‐associated plasma protein A2 cause short stature due to low IGF‐I availability

A Dauber, MT Muñoz‐Calvo, V Barrios… - EMBO molecular …, 2016 - embopress.org
Mutations in multiple genes of the growth hormone/IGF‐I axis have been identified in
syndromes marked by growth failure. However, no pathogenic human mutations have been …

Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity

JK Christians, AK Bath, N Amiri - Growth Hormone & IGF Research, 2015 - Elsevier
Objective Insulin-like growth factor binding proteins (IGFBPs) are involved in glucose and
lipid metabolism, and their actions are modulated by proteases. The aim of this study was to …

[PDF][PDF] Novel modulators of the growth hormone-insulin-like growth factor axis: pregnancy-associated plasma protein-A2 and stanniocalcin-2

M Fujimoto, V Hwa, A Dauber - Journal of Clinical Research in …, 2017 - jag.journalagent.com
Growth hormone (GH) and its mediator, insulin-like growth factor-1 (IGF-1), play a critical
role in human growth. In circulation, IGF-1 is found in a ternary complex with IGF binding …

Short stature with low insulin‐like growth factor 1 availability due to pregnancy‐associated plasma protein A2 deficiency in a Saudi family

A Babiker, K Al Noaim, A Al Swaid, M Alfadhel… - Clinical …, 2021 - Wiley Online Library
In 2016 a new syndrome with postnatal short stature and low IGF1 bioavailability caused by
biallelic loss‐of‐function mutations in the gene encoding the metalloproteinase pregnancy …

Treatment with recombinant human insulin-like growth factor-1 improves growth in patients with PAPP-A2 deficiency

MT Muñoz-Calvo, V Barrios, J Pozo… - The Journal of …, 2016 - academic.oup.com
Context: Pregnancy-associated plasma protein-A2 (PAPP-A2) is a metalloproteinase that
specifically cleaves IGFBP-3 and IGFBP-5. Mutations in the PAPP-A2 gene have recently …

Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for …

X Yan, RC Baxter, SM Firth - The Journal of Clinical …, 2010 - academic.oup.com
Context: During pregnancy, circulating IGF binding protein-5 (IGFBP-5) undergoes
substantial molecular redistribution from ternary complexes to either binary complexes or the …